Evidence map›Paper›PMID 42356437›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

The Extract of

Suk Ju, Joonyoung Shin, Hyorin Lee, Gwang Joo Jeon, Dongwoon Han, Sungchul Kim

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Suk JuInstitute for Global Rare Disease Network, Professional Graduate School of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea.
Joonyoung ShinInstitute for Global Rare Disease Network, Professional Graduate School of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea.ORCID 0000-0002-5064-6227
Hyorin LeeInstitute for Global Rare Disease Network, Professional Graduate School of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea.
Gwang Joo JeonDepartment of Biotechnology, Hankyong National University, Anseong 17579, Republic of Korea.ORCID 0000-0003-3868-2281
Dongwoon HanInstitute for Global Rare Disease Network, Professional Graduate School of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea.ORCID 0000-0003-0206-8976
Sungchul KimInstitute for Global Rare Disease Network, Professional Graduate School of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea.ORCID 0009-0002-9513-0758

Funding

Wonkwang University 2026
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HongdanMAPK signaling pathwaysmicroglianitritepro-inflammatory cytokinesSalvia miltiorrhiza

Identifiers

PMID42356437
PMCPMC13305418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.